Quantbot Technologies LP Novo Cure LTD Transaction History

Quantbot Technologies LP

$2.36 Billion
Q3 2024

A detailed history of Quantbot Technologies LP transactions in Novo Cure LTD stock. As of the latest transaction made, Quantbot Technologies LP holds 40,830 shares of NVCR stock, worth $688,393. This represents 0.03% of its overall portfolio holdings.

Number of Shares

40,830

Previous 56,247 27.41%

Holding current value

$688,393

Previous $963,000 33.75%

% of portfolio

0.03%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.61 - $23.34 $240,659 - $359,832	-15,417 Reduced 27.41%	40,830 $638,000
Q2 2024 Aug 09, 2024	SELL	$11.83 - $24.05 $100,898 - $205,122	-8,529 Reduced 13.17%	56,247 $963,000
Q1 2024 May 06, 2024	BUY	$12.42 - $17.29 $207,178 - $288,414	16,681 Added 34.68%	64,776 $1.01 Million
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $557,412 - $790,293	-50,082 Reduced 51.01%	48,095 $718,000
Q3 2023 Nov 07, 2023	BUY	$16.15 - $42.35 $1.41 Million - $3.71 Million	87,579 Added 826.37%	98,177 $1.59 Million
Q2 2023 Aug 08, 2023	BUY	$40.29 - $82.51 $426,993 - $874,440	10,598 New	10,598 $439,000
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $276,585 - $369,054	4,323 Added 158.53%	7,050 $517,000
Q3 2022 Nov 07, 2022	SELL	$67.99 - $89.57 $1.03 Million - $1.36 Million	-15,131 Reduced 84.73%	2,727 $207,000
Q2 2022 Aug 09, 2022	BUY	$56.6 - $89.9 $1.01 Million - $1.61 Million	17,858 New	17,858 $1.24 Million
Q4 2021 Feb 11, 2022	SELL	$75.08 - $121.99 $1.34 Million - $2.18 Million	-17,841 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$116.17 - $194.55 $2.07 Million - $3.47 Million	17,841 New	17,841 $2.07 Million
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $123,619 - $213,849	-948 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $117,656 - $180,281	948 New	948 $125,000
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $436,710 - $837,385	-7,523 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $430,315 - $559,786	7,523 New	7,523 $446,000
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $451,893 - $758,435	-7,921 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$68.3 - $93.8 $541,004 - $742,989	7,921 New	7,921 $667,000
Q3 2019 Nov 12, 2019	SELL	$61.86 - $97.8 $72,005 - $113,839	-1,164 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$42.22 - $63.23 $384,919 - $576,467	-9,117 Reduced 88.68%	1,164 $73,000
Q1 2019 May 13, 2019	BUY	$31.96 - $56.12 $328,580 - $576,969	10,281 New	10,281 $495,000
Q1 2018 May 11, 2018	SELL	$19.3 - $23.65 $173,487 - $212,589	-8,989 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$16.3 - $21.9 $146,520 - $196,859	8,989	8,989 $181,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Novo Cure LTD Transaction History